BOSTON, April 11 (Reuters) - A trial of Celgene Inc.'s (CELG.O: Quote, Profile , Research) cancer drug Revlimid was temporarily suspended as of April 4, according to the Southwest Oncology Group, or SWOG, which was running the late-stage trial.
BOSTON, April 11 (Reuters) - A trial of Celgene Inc.'s (CELG.O: Quote, Profile , Research) cancer drug Revlimid was temporarily suspended as of April 4, according to the Southwest Oncology Group, or SWOG, which was running the late-stage trial.
